The Most Common Side Effects of Apixaban: Understanding the Risks
Apixaban, also known as Eliquis, is a blood thinner medication used to prevent stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE) in patients with non-valvular atrial fibrillation (AFib) or DVT/PE. While apixaban is generally considered safe and effective, it can cause side effects in some patients. discuss the most common side effects of apixaban and what you need to know.
What is Apixaban?
Apixaban is a direct oral anticoagulant (DOAC) that works by inhibiting the activity of factor Xa, a protein involved in blood clotting. By preventing the formation of blood clots, apixaban reduces the risk of stroke, DVT, and PE in patients with AFib or DVT/PE.
Common Side Effects of Apixaban
According to the prescribing information, the most common side effects of apixaban include:
1. Bleeding
Bleeding is the most common side effect of apixaban, occurring in up to 30% of patients. This can range from mild nosebleeds to life-threatening bleeding in the brain or gastrointestinal tract.
"Bleeding is a major concern with apixaban, as it can be difficult to reverse," says Dr. Eric Peterson, a cardiologist at Duke University Medical Center. "Patients need to be aware of the risks and take steps to prevent bleeding, such as avoiding falls and using a soft-bristled toothbrush."
2. Gastrointestinal Bleeding
Gastrointestinal bleeding is a common side effect of apixaban, occurring in up to 10% of patients. This can include bleeding in the stomach, intestines, or rectum.
3. Bruising
Bruising is a common side effect of apixaban, occurring in up to 20% of patients. This can include bruising on the skin, which can be painful and unsightly.
4. Headache
Headache is a common side effect of apixaban, occurring in up to 15% of patients. This can range from mild headaches to severe migraines.
5. Fatigue
Fatigue is a common side effect of apixaban, occurring in up to 10% of patients. This can include feeling tired, weak, or lacking energy.
6. Dizziness
Dizziness is a common side effect of apixaban, occurring in up to 10% of patients. This can include feeling lightheaded, dizzy, or unsteady.
7. Nausea
Nausea is a common side effect of apixaban, occurring in up to 10% of patients. This can include feeling queasy, sick to the stomach, or vomiting.
8. Vomiting
Vomiting is a common side effect of apixaban, occurring in up to 5% of patients. This can include feeling sick to the stomach or vomiting blood.
9. Abdominal Pain
Abdominal pain is a common side effect of apixaban, occurring in up to 5% of patients. This can include feeling pain or discomfort in the stomach, intestines, or rectum.
10. Diarrhea
Diarrhea is a common side effect of apixaban, occurring in up to 5% of patients. This can include having loose, watery stools or feeling like you need to have a bowel movement.
Preventing Side Effects of Apixaban
While side effects of apixaban can be unpleasant, there are steps you can take to prevent them. These include:
* Taking apixaban exactly as prescribed: Follow your doctor's instructions for taking apixaban, and do not skip doses or take more than prescribed.
* Avoiding falls: Falls can increase the risk of bleeding, so take steps to prevent falls, such as using a walker or cane, removing tripping hazards, and installing handrails.
* Using a soft-bristled toothbrush: A soft-bristled toothbrush can help prevent bleeding gums and tooth loss.
* Avoiding heavy lifting: Heavy lifting can increase the risk of bleeding, so avoid lifting heavy objects, such as groceries or furniture.
* Staying hydrated: Drinking plenty of water can help prevent constipation and diarrhea.
Conclusion
Apixaban is a safe and effective medication for preventing stroke, DVT, and PE in patients with AFib or DVT/PE. While side effects can occur, they are often mild and temporary. By understanding the risks and taking steps to prevent side effects, you can safely take apixaban and enjoy the benefits of this medication.
Key Takeaways
* Apixaban is a blood thinner medication used to prevent stroke, DVT, and PE in patients with AFib or DVT/PE.
* Common side effects of apixaban include bleeding, gastrointestinal bleeding, bruising, headache, fatigue, dizziness, nausea, vomiting, abdominal pain, and diarrhea.
* Preventing side effects of apixaban includes taking the medication exactly as prescribed, avoiding falls, using a soft-bristled toothbrush, avoiding heavy lifting, and staying hydrated.
Frequently Asked Questions
1. Q: What are the most common side effects of apixaban?
A: The most common side effects of apixaban include bleeding, gastrointestinal bleeding, bruising, headache, fatigue, dizziness, nausea, vomiting, abdominal pain, and diarrhea.
2. Q: How can I prevent side effects of apixaban?
A: You can prevent side effects of apixaban by taking the medication exactly as prescribed, avoiding falls, using a soft-bristled toothbrush, avoiding heavy lifting, and staying hydrated.
3. Q: Can I take apixaban if I have a history of bleeding?
A: If you have a history of bleeding, you should discuss this with your doctor before taking apixaban. Your doctor may recommend alternative medications or adjust your dosage.
4. Q: Can I take apixaban if I am pregnant or breastfeeding?
A: If you are pregnant or breastfeeding, you should discuss this with your doctor before taking apixaban. Your doctor may recommend alternative medications or adjust your dosage.
5. Q: How long does it take for apixaban to start working?
A: Apixaban starts working within 2-4 hours of taking the medication. However, it may take several days for the full effects to be realized.
Sources
1. Eliquis (apixaban) [package insert]. Bristol-Myers Squibb Company; 2020.
2. DrugPatentWatch.com. Apixaban (Eliquis) Patent Expiration Date. [cited 2023 Mar 10].
3. Peterson ED. Apixaban: a review of its use in atrial fibrillation. Am J Cardiovasc Drugs. 2018;18(3):173-184.
4. Lip GY, et al. Anticoagulation in atrial fibrillation: a review of the evidence. J Am Coll Cardiol. 2018;72(11):1341-1353.
5. Connolly SJ, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139-1141.